Response to induction therapy by day 9 serum DNR and DNR-ol concentration and assigned treatment
| DNR or DNR-ol (ng/mL) . | AraC-DNR . | AraC-DNR + CsA . | ||||
|---|---|---|---|---|---|---|
| Patients . | Percent CR . | Percent RD . | Patients . | Percent CR . | Percent RD . | |
| DNR | ||||||
| 0-9.99 | 23 | 39 | 48 | 9 | 22 | 56 |
| 10-29.99 | 25 | 48 | 32 | 31 | 58 | 23 |
| ≥ 30 | 14 | 7 | 50 | 20 | 50 | 25 |
| DNR-ol | ||||||
| 0-49.99 | 30 | 47 | 37 | 5 | 20 | 60 |
| 50-199.99 | 27 | 22 | 48 | 27 | 41 | 41 |
| ≥ 200 | 5 | 40 | 40 | 32 | 63 | 13 |
| DNR or DNR-ol (ng/mL) . | AraC-DNR . | AraC-DNR + CsA . | ||||
|---|---|---|---|---|---|---|
| Patients . | Percent CR . | Percent RD . | Patients . | Percent CR . | Percent RD . | |
| DNR | ||||||
| 0-9.99 | 23 | 39 | 48 | 9 | 22 | 56 |
| 10-29.99 | 25 | 48 | 32 | 31 | 58 | 23 |
| ≥ 30 | 14 | 7 | 50 | 20 | 50 | 25 |
| DNR-ol | ||||||
| 0-49.99 | 30 | 47 | 37 | 5 | 20 | 60 |
| 50-199.99 | 27 | 22 | 48 | 27 | 41 | 41 |
| ≥ 200 | 5 | 40 | 40 | 32 | 63 | 13 |